REHOVOT, Israel (AP) _ Kamada Ltd. (KMDA) on Tuesday reported fourth-quarter profit of $17.7 million.
On a per-share basis, the Rehovot, Israel-based company said it had profit of 44 cents. Earnings, adjusted for stock option expense, were 45 cents per share.
The biopharmaceutical posted revenue of $48.2 million in the period.
For the year, the company reported profit of $22.3 million, or 55 cents per share. Revenue was reported as $114.5 million.
Kamada expects full-year revenue in the range of $125 million to $130 million.
Kamada shares have increased almost 9 percent since the beginning of the year. The stock has climbed nearly 9 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KMDA at https://www.zacks.com/ap/KMDA